At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 74 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Gabapentin 600mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of Gabapentin for Post-Operative Pain Control and Narcotic Reduction in Scrotal Surgery
In Brief
A Phase 3 clinical trial evaluating Gabapentin and Placebo for Non-obstructive Azoospermia. Completed, enrolled 74 participants across 1 site.
Detailed Summary
The use of non-narcotic multi-modal analgesia to be used in the pre-operative, peri-operative and post-operative period to reduce or potentially eliminate narcotic usage following scrotal surgery. Research study results have shown that the use of anti-inflammatories in the peri-operative period reduces both pain and narcotic use. The hypothesis is that adding another agent in the multi-modal pathway will further reduce pain and potentially reduce narcotic usage.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-obstructive Azoospermia
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartJul 2020
Primary CompletionNov 2022
Study CompletionDec 2022
TodayJul 2026
First PostedJan 18, 2020
Enrollment StartJul 28, 2020
Primary CompletionNov 28, 2022
Study CompletionDec 16, 2022
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.5 years ago
Interventions
Gabapentindrug
Gabapentin 600mg tablet
Placebodrug
Placebo tablet